Journal: Cells
Article Title: Therapeutic Potential of Olfactory Ensheathing Cells and Adipose-Derived Stem Cells in Osteoarthritis: Insights from Preclinical Studies
doi: 10.3390/cells13151250
Figure Lengend Snippet: Adipose stem cell (ASC) characterization. ( A , B ) morphology of ADSC. Scale bar = 100 μm. ( C ) Flowcytometry of ASC. Positive for CD44, CD73, CD90, CD105, and HLA-ABC and negative for CD34, CD45, and HLA-DR. ( D – F ) qRT-PCR showed the gene expressions of adipogenesis ( FABP4 , PPARγ ) ( D ), osteogenesis ( ALPL , RUNX2 ) ( E ), and chondrogenesis (aggrecan and COL2A1 ) ( F ). ( G ) Oil red staining of differentiated cells after adipogenesis. ( H ) Quantification of Oil Red at OD 510. ( I ) Alizarin Red staining of differentiated cells after osteogenesis. ( J ) Quantification of Alizarin Red at OD552. ( K – O ) Characterization of differentiated cell after chondrogenesis. Pellet morphology ( K ), H & E ( L ), Safranin O ( M ), aggrecan ( N ), and type II collagen ( O ). ** p < 0.01, *** p < 0.001. Scale bar = 100 μm.
Article Snippet: Subsequently, the sections were blocked with Ultra V block (Thermo Scientific) for 10 min and then incubated with primary antibodies against type II collagen and aggrecan (1:200, GeneTex, Irvine, CA, USA) at 37 °C for 4 h. The secondary antibodies used were biotin-labeled goat anti-rabbit immunoglobulin (Dako, Carpinteria, CA, USA) and horseradish peroxidase-conjugated streptavidin (Biocare Medical), which were incubated for 30 min.
Techniques: Quantitative RT-PCR, Staining